Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market to Reach an Estimated Value of USD 15.9 Billion in 2020: Transparency Market Research

Aug 19, 2015, 10:00 ET from Transparency Market Research

ALBANY, New York, August 19, 2015 /PRNewswire/ --

Surging prevalence of different types of cancers across the globe and technological advances have driven the novel drug delivery systems (NDDS) in cancer therapy market, states Transparency Market Research in its latest publication. The report, titled "Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market (Drug Eluting Beads, Polyvinyl Alcohol (PVA) Particles, Microspheres, Gelatin-based Embolization Devices, Selective Internal Radiation Therapy (SIRT), Onyx, TRUFILL n Butyl Cyano Acrylate (nBCA) Liquid Embolic System and Nanoparticles) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020", indicates that registering a CAGR of 23.7% from 2014 to 2020, the global NDDS in cancer therapy market is estimated to rise from a value of US$3.6 billion in 2013 to US$15.9 billion by 2020.

Browse Market Research Report on Novel Drug Delivery Systems in Cancer Therapy Market: http://www.transparencymarketresearch.com/ndds-in-cancer-therapy-market.html

By technology, the NDDS in cancer therapy market is segmented into liquid embolics, embolization particles, and nanoparticles. The nanoparticles drug delivery system is known to account for the largest share in terms of revenue, valuing US$3,307.7 million in 2013. Growing at a remarkable CAGR of 24.7% from 2014 to 2020, this segment holds the most lucrative opportunities according to market analysts. Nanoparticles such as Abraxane (paclitaxel), Megace ES (megestrol acetate), DepoCyt (liposomal cytarabine), Myocet (doxorubicin), DaunoXome (daunorubicin citrate), and Doxil (doxorubicin) have already received approval as NDDS in cancer therapy. The segment of liquid embolics is anticipated to register a 4.9% CAGR during the forecast period.

Get Sample Report Copy of Drug Delivery Systems in Cancer Therapy Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3590

On the basis of geography, the global NDDS in cancer therapy market is divided into North America, Europe, Asia Pacific, and Rest of the World. Rising number of patients suffering from different types of cancer, favorable reimbursement scenario, and advanced healthcare infrastructure have driven North America to become the leading regional segment in the global NDDS in cancer therapy market. In 2013, this region enjoyed a 46.6% share of the overall market and this is expected to rise to 49.7% by 2020, developing at an impressive CAGR of 24.9% during that period.

Browse Press Release of Drug Delivery Systems in Cancer Therapy Market: http://www.transparencymarketresearch.com/pressrelease/ndds-in-cancer-therapy-market.htm

With a 29.2% share of the global NDDS in cancer therapy market in 2013, Europe came in after North America, fueled by large number of pipeline products and technological advances resulting in the development of new and innovative products.

Other Reports Published by Transparency Market Research:  



Growing at a strong CAGR of 22.6% from 2014 to 2020, the Asia Pacific NDDS in cancer therapy market is poised for steady growth owing to the development of emerging economies such as China, Japan, India, New Zealand, and Australia. Rising market penetration by leading players is another factor driving this market.

Browse Upcoming Market Research Reports:  



The leading participants in the NDDS in cancer therapy market include Advanced Medical Isotope Corporation, Mo-Sci Corporation, Eckert & Ziegler BEBIG, Cospheric LLC, Bind Therapeutics, Sirtex Medical, Inc., Polysciences, Inc., BTG plc, Nanobiotix, Kobo Products, Inc., CeloNova BioSciences, Inc., Terumo Medical Corporation., Covidien, plc, Merit Medical Systems, Inc., EmboMedics, Inc., Boston Scientific Corporation, and Cook Medical, Inc.

NDDS in Cancer Therapy Market, by Technology 

  • Embolization Particles
    • Current Technologies
      • Drug Eluting Beads
      • Others (PVA particles, microspheres, gelatin-based)
    • Emerging Technologies
      • Selective Internal Radiation Therapy (SIRT)
        • TheraSphere
        • SIR-Spheres
      • Holmium-based Microspheres
  • Liquid Embolics
    • Onyx (LES and HD-500)
    • TRUFILL nBCA LES
  • Nanoparticles

NDDS in Cancer Therapy Market, by Geography 

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Browse All Other Medical Devices Market Research Reports: http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact
Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.europlat.org


SOURCE Transparency Market Research